Ideas to Action:

Independent research for global prosperity

CGD Policy Blogs

 

A Reflective Moment for PEPFAR

It is a rare moment when researchers, policymakers, and implementers are in the same room talking about the same thing. But this is happening next week at the IOM workshop on Design Considerations for Evaluating the Impact of PEPFAR. Held Monday, April 30 and Tuesday, May 1 at the National Academies in downtown Washington, this public meeting is being convened to discuss methodological, policy and practical design considerations for the future evaluation of the President's Emergency Plan for AIDS Relief.

World Bank Board Pushes Back on Family Planning

Reuters reported today that World Bank's Executive Board yesterday postponed a decision on a proposed new Health, Nutrition and Population (HNP) strategy in a tussle over words with potentially far-reaching impact. According to the report, the U.S. executive director wanted to amend the strategy to recommend “age appropriate access to sexual and reproductive healthcare" -- language that the Europeans said could restrict younger women's access to contraception and other reproductive services in poor countries.

US Presidential Candidates Put Development on the Agenda

Barack Obama's powerful foreign policy speech in Chicago on Monday laid out a clear vision for regaining US leadership in the world, including on critical issues confronting the poorest countries of the world. Senator Obama called for strengthening the operations of the United Nations, World Bank and other multilateral institutions to solve the world's most pressing problems, rather than just attacking them.

"Patient" Capital for Africa

Thomas Friedman’s op-ed (subscription required), "'Patient' Capital for an Africa that Can't Wait," in last Friday’s (April 20) New York Times calls for a new kind of venture capital for Africa that accepts lower (but still positive) returns on risk capital over a longe

On the Road to Universal Access: Are We There Yet?

Treating people seemed relatively easy compared to existing prevention efforts when ARVs emerged on the AIDS scene. Largely due to activist efforts, drugs were quickly produced in large enough quantities and eventually at an affordable price for donors to provide to millions of people in the developing world. Expectations for rapid scale up of treatment programs were hopefully high, but hopelessly unrealistic.

MeTA: Spotlight on the Supply Chain

As new funders, like UNITAID, buy more new drugs on behalf of the poorest countries, weak links in the supply chain are more visible than they have ever been - and the stakes are higher. Among the signs of a supply chain under pressure: procurement bottlenecks, high mark-ups by intermediaries, uninterpretable signals to suppliers about effective demand and stock-outs. And the result: reduced access to life-saving drugs, high out-of-pocket spending, rapid emergence of drug resistance and other negative consequences for individuals, families and communities.

Pages